Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

High-Dose Quinapril Versus Low-Dose Quinapril Plus Amlodipine in the Treatment of High-Risk Hypertensive Patients

This study has been terminated.
(Very difficult to recruit patients/slow recruitment(2 patients in nearly 2 years).)
Sponsor:
Collaborator:
Pfizer
Information provided by:
Montreal Heart Institute
ClinicalTrials.gov Identifier:
NCT00313547
First received: April 10, 2006
Last updated: May 2, 2008
Last verified: August 2007
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Study Completion Date: March 2008
  Primary Completion Date: April 2007 (Final data collection date for primary outcome measure)